Search form
Search
contact us
Navigation
home
boards
job center
job ratings
cp wire
device news
pharmagather
catering
advertise
Legal Help
login/register
You are here
Home
»
companies
» Inovio
Inovio
Clinical developments over the holidays
Clinical developments over the holidays
EP Vantage
Aprea Therapeutics
Arcturus Therapeutics
Axsome Therapeutics
Inovio
Regeneron
clinical trials
oncology
vaccines
COVID-19
Flag link:
Inovio doses first patient in phase 2 segment of Covid-19 DNA vaccine candidate trial
Inovio doses first patient in phase 2 segment of Covid-19 DNA vaccine candidate trial
Pharmaceutical Business Review
Inovio
clinical trials
vaccines
INO-4800
COVID-19
Flag link:
Inovio secures FDA nod for phase 2 segment of Covid-19 DNA vaccine candidate trial
Inovio secures FDA nod for phase 2 segment of Covid-19 DNA vaccine candidate trial
Pharmaceutical Business Review
Inovio
FDA
COVID-19
vaccines
clinical trials
Flag link:
Inovio Jumps on Progress of Coronavirus Vaccine Candidate
Inovio Jumps on Progress of Coronavirus Vaccine Candidate
TheStreet.com
Inovio
vaccines
clinical trials
COVID-19
Flag link:
Inovio Forced To Delay Planned Phase 2/3 Testing Of Covid-19 Vaccine; Stock Plummets
Inovio Forced To Delay Planned Phase 2/3 Testing Of Covid-19 Vaccine; Stock Plummets
Investors Business Daily
Inovio
COVID-19
vaccines
clinical trials
Flag link:
Which Biotech Company Has the Most Promising Coronavirus Vaccine?
Which Biotech Company Has the Most Promising Coronavirus Vaccine?
Motley Fool
COVID-19
pandemic
vaccines
Moderna Therapeutics
Pfizer
BioNTech
AstraZeneca
Inovio
Flag link:
Here's Why Inovio Is The Front-Runner In Developing a Coronavirus Vaccine
Here's Why Inovio Is The Front-Runner In Developing a Coronavirus Vaccine
Motley Fool
vaccines
INO-4800
COVID-19
pandemic
Inovio
Flag link:
Inovio claims positive results on Covid-19 vaccine but critical data are missing
Inovio claims positive results on Covid-19 vaccine but critical data are missing
Stat
Inovio
vaccines
clinical trials
COVID-19
Flag link:
Inovio gets $71 mln from U.S. DoD for COVID-19 vaccine device
Inovio gets $71 mln from U.S. DoD for COVID-19 vaccine device
Reuters
Inovio
Department of Defense
vaccines
COVID-19
pandemic
Flag link:
The coronavirus vaccine frontrunners have emerged. Here's where they stand
The coronavirus vaccine frontrunners have emerged. Here's where they stand
BioPharma Dive
COVID-19
vaccines
Moderna Therapeutics
Cansino Biologics
Pfizer
BioNTech
Novavax
Inovio
Oxford BioMedica
AstraZeneca
Merck
JNJ
Sanofi
GSK
Flag link:
Is Moderna Really the Leader in the COVID-19 Vaccine Race?
Is Moderna Really the Leader in the COVID-19 Vaccine Race?
Motley Fool
vaccines
COVID-19
Moderna Therapeutics
AstraZeneca
Pfizer
JNJ
BioNTech
Merck
Sanofi
GSK
Novavax
Inovio
Flag link:
Caught in a standoff with its contract manufacturer over Covid-19 vaccine, Inovio files suit in an attempt to break free while rivals race ahead
Caught in a standoff with its contract manufacturer over Covid-19 vaccine, Inovio files suit in an attempt to break free while rivals race ahead
Endpoints
Inovio
vaccines
COVID-19
VGXI
Flag link:
Results From Oxford University's Human Trial Of Coronavirus Vaccine Could Arrive In June; Where Inovio, Moderna Stand
Results From Oxford University's Human Trial Of Coronavirus Vaccine Could Arrive In June; Where Inovio, Moderna Stand
Yahoo/Benzinga
University of Oxford
AstraZeneca
Inovio
Moderna Therapeutics
pandemic
vaccines
COVID-19
Flag link:
Is Inovio Gaining Ground in the Coronavirus Vaccine Race?
Is Inovio Gaining Ground in the Coronavirus Vaccine Race?
Motley Fool
Inovio
Moderna Therapeutics
vaccines
clinical trials
pandemic
COVID-19
Flag link:
Inovio's COVID-19 vaccine claims echo Theranos, says short attack
Inovio's COVID-19 vaccine claims echo Theranos, says short attack
Fierce Pharma
Inovio
vaccines
COVID-19
Citron Research
Theranos
Flag link:
Inovio Ramps Up Production of Its Coronavirus Vaccine Candidate
Inovio Ramps Up Production of Its Coronavirus Vaccine Candidate
Motley Fool
Inovio
INO-4800
COVID-19
vaccines
drug manufacturing
Flag link:
Don't count on a COVID-19 vaccine for at least 5 years, says AI-based forecast
Don't count on a COVID-19 vaccine for at least 5 years, says AI-based forecast
Fierce Pharma
Clarivate Analytics
vaccines
artificial intelligence
Moderna Therapeutics
Inovio
COVID-19
Flag link:
5 Biotech Stocks Winning the Coronavirus Race
5 Biotech Stocks Winning the Coronavirus Race
Motley Fool
COVID-19
pandemic
drug development
Regeneron
Kevzara
Gilead Sciences
remdesivir
Inovio
INO-4800
vaccines
Moderna Therapeutics
mRNA-1273
Novavax
NVX-CoV2373
Flag link:
The long path to an effective coronavirus vaccine
The long path to an effective coronavirus vaccine
EP Vantage
vaccines
COVID-19
coronaviruses
Moderna Therapeutics
Shenzhen Genoimmune
Cansino Biologics
Pfizer
BioNTech
Inovio
JNJ
Altimmune
Heat Biologics
iBio
EpiVax
Flag link:
Johnson & Johnson's Coronavirus Vaccine Won't Be in Clinical Trials Until November
Johnson & Johnson's Coronavirus Vaccine Won't Be in Clinical Trials Until November
Motley Fool
JNJ
Inovio
Moderna Therapeutics
vaccines
COVID-19
coronaviruses
Flag link:
Pages
1
2
3
4
5
6
7
next ›
last »